b r i e f c o m m u n i c a t i o n s Although dietary gluten is the trigger for celiac disease, risk is strongly influenced by genetic variation in the major histocompatibility complex (MHC) region. We fine mapped the MHC association signal to identify additional risk factors independent of the HLA-DQA1 and HLA-DQB1 alleles and observed five new associations that account for 18% of the genetic risk. Taking these new loci together with the 57 known non-MHC loci, genetic variation can now explain up to 48% of celiac disease heritability.
Celiac disease is an autoimmune disease triggered by the consumption of dietary gluten in which the primary organ affected is the small intestine. The MHC region is the main genetic factor in disease development, with the strongest effects mapped to the classical HLA-DQA1 and HLA-DQB1 genes. Specifically, the common haplotypes DQ2.5, DQ2.2 and DQ8 have been shown to increase disease risk by sixfold on average 1, 2 . Genome-wide association analyses have identified another 57 independent SNPs located in 39 risk loci outside the MHC 3, 4 . In this study, we hypothesized that a substantial fraction of heritability for celiac disease might be explained by unknown independent variants across the MHC (but outside the classical HLA-DQA1 and HLA-DQB1 region). These variants might have remained undetected in previous genome-wide association studies owing to the complexities of fine mapping association signals in the extended MHC region. We therefore imputed the region and tested for associated SNPs, amino acid polymorphisms and classical human leukocyte antigen (HLA) alleles in 12,016 celiac disease cases and 11,920 controls of European ancestry (in 6 cohorts from 5 countries), all genotyped on the Illumina Immunochip array (Online Methods and Supplementary Table 1 ).
Because HLA class II haplotypes are established risk factors for celiac disease, we first focused on the region encompassing HLA-DRB1, HLA-DQA1 and HLA-DQB1. Consistent with functional studies, we confirmed strong associations in favor of HLA-DQ (P = 1 × 10 −177 for a direct comparison between all classical four-digit alleles of HLA-DQA1 and HLA-DQB1 relative to those of HLA-DRB1; Online Methods and Supplementary Table 2 ). We also observed remarkable differences in allele frequency across European populations ( Supplementary Fig. 1 and Supplementary Table 3 ). In a stepwise conditional analysis within the HLA-DQ heterodimer molecule, we identified amino acid positions 25 and 47 in HLA-DQα1 and amino acid positions 57 and 74 in HLA-DQβ1 as the strongest independent associations with celiac disease risk ( Supplementary Fig. 2 and Supplementary Table 4 ). The haplotype model based on these four associated amino acid positions, of which residues 57 and 74 in HLA-DQβ1 are thought to make direct contact with the epitope in the HLA-DQ binding groove, almost perfectly recapitulated the associations with the classical HLA-DQA1 and HLA-DQB1 alleles (99.6% of the explained variance). For example, the haplotype defined by HLA-DQα1 Tyr25/Cys47 and HLA-DQβ1 Ala57/Ala74 completely mirrors the risk conferred by HLA-DQ2.5 (amino acid haplotype odds ratio (OR) = 19.13, P = 1 × 10 −1,754 ; HLA-DQ2.5 OR = 21.56, P = 1 × 10 −1,801 ) ( Supplementary Tables 2 and 4) .
To identify additional associations beyond HLA-DQ, we tested all the other variants across the MHC region after correcting for the collective effects of all classical HLA-DQA1 and HLA-DQB1 four-digit alleles. We identified five further independent variants with genomewide significance: amino acid position 9 in HLA-DPβ1 (omnibus P = 1 × 10 −41 ), classical alleles HLA-B*08:01 (P = 1 × 10 −22 ) and HLA-B*39:06 (P = 1 × 10 −8 ), and two SNPs, rs1611710 (P = 1 × 10 −9 ) and rs2301226 (P = 1 × 10 −9 ) ( Fig. 1, Supplementary Fig. 3 and Supplementary Table 5 ). Expression quantitative trait locus (eQTL) analysis of publicly available data sets 5 demonstrated a cis-eQTL effect of rs1611710 on HLA-F expression (eQTL P = 1.22 × 10 −56 ) and of rs2301226 on B3GALT4 (eQTL P = 1.67 × 10 −39 ) and HLA-DPB1 (eQTL P = 3.87 × 10 −13 ) expression. When we did not adjust a priori for the effects of the HLA-DQA1 and HLA-DQB1 alleles, we found the same five independent effects, in addition to several strong effects in the class II region ( Supplementary Fig. 4 and Supplementary Table 5 ), providing support for the robustness of these findings.
On the basis of all the genetic associations for celiac disease risk, we estimated the genetic variance explained (h 2 ) with a liability threshold model, assuming a disease prevalence of 1% ( Table 1 and Online Methods) [6] [7] [8] [9] [10] . The classical HLA-DQA1 and HLA-DQB1 loci alone explain h 2 = 0.232 on the liability scale, whereas the 5 newly discovered variants reported here explain an additional h 2 = 0.180, which is more Fine mapping in the MHC region accounts for 18% additional genetic risk for celiac disease than twice the variance explained by the 57 independent SNPs outside the MHC region 3 (h 2 = 0.065). In total, all the variants identified thus far as being robustly associated with celiac disease risk explain approximately h 2 = 0.477. These liability estimates are more modest than those previously published (~87% explained genetic risk 11 ). This discrepancy illustrates the difficulty in comparing explained variance estimates between studies if the model assumptions are not the same 12 . When we changed the assumed prevalence to 2% or 3%, as reported in some populations (Online Methods), we observed substantially increased heritability estimates, which demonstrates not only how sensitive the estimates are to this parameter but also how estimates may change in populations with an empirically higher disease prevalence ( Supplementary Table 6 ).
Although the importance of the MHC region in celiac disease and other autoimmune diseases is widely recognized, the particular properties of the region 13 have made it difficult to identify independent loci and pinpoint functional variants that have a role in disease pathology. Taking advantage of high-density imputation 14 , we have implicated a set of five variants ( Fig. 1 and Supplementary Figs. 2  and 3 ) that act independently of HLA-DQ and that can explain an additional 18% of celiac disease heritability. On the basis of these results, it seems likely that fine mapping the MHC region in other diseases with classical HLA associations will identify some of the 'missing' heritability.
Finally, this study provides evidence that the MHC class I region is also an important locus in celiac disease etiology. This is an interesting observation given the presumed role for TCRαβ + CD8αβ + intraepithelial lymphocytes (IELs), which have been shown to exacerbate celiac disease and are restricted to MHC class I recognition 15 . These cells represent a subtype of antigen-experienced 'innate-like' T cells, and, under conditions of homeostasis, they are located within the intestinal mucosa, maintaining epithelium integrity and preventing pathogen incursion. TCRαβ + CD8αβ + cells are most abundant in the intestinal mucosa (70-80% of the IEL subset) and are a hallmark of celiac disease because of their correlation with gluten intake, thereby providing further support for the role of IELs in the etiology of celiac disease.
Methods
Methods and any associated references are available in the online version of the paper. b r i e f c o m m u n i c a t i o n s npg where D represents the deviance, which follows an approximate χ 2 distribution with k degrees of freedom represented by the difference in the regressed parameter between the two models. The null model is represented by:
The method described above was applied to determine specific amino acid associations for HLA-DQα1 and HLA-DQβ1 ('DQ model') and also to test two other models: (i) a 'relaxed model' , which aimed to find HLA associations in an unbiased way, and (ii) a 'conservative model' , where we adjusted for all classical HLA-DQA1 and HLA-DQB1 alleles. For each of these models, stepwise conditional analysis was performed as follows:
Step 1. To determine the top associations in each of the models (DQ model, relaxed model and conservative model), we compared a null model to an alternative model by including each of the variants in the analysis (SNPs, classical HLA alleles and HLA amino acids). For the DQ model and the relaxed model, the initial null model was calculated as given in equation (3), whereas the alternative model was calculated as given in equation (1) . For the conservative model, we used all of the terms described in equation (3) but also included all HLA-DQA1 and HLA-DQB1 four-digit classical alleles as covariates.
Step 2. For each of the three models, we compared the null model with the alternative models from step 1. P values were obtained as described in equation (2). The best-fitted variant was chosen as the top association and subsequently included in the null and alternative models for each of the three models in the next round of analysis (in this case, each new alternative model included sex, country, the best-fitted variant and the variant being tested for association).
Step 3. The new null model was again compared with each of the alternative models in a forward fashion until no residual association was found in the region.
With the phased data from imputation, we determined all the common classical haplotypes (HLA-DRB1-HLA-DQA1-HLA-DQB1) present at a frequency of >1% using the entire sample and the knowledge of HLA haplotypes observed in European populations 20 . With these haplotypes, we calculated the frequency and provided risk. We determined whether each individual was a carrier of 0, 1 or 2 copies of the haplotype under analysis. We used logistic regression with sex and origin as covariates to determine the association with celiac disease. All the association analysis was carried out with R statistical software (v3.1) 21 .
Variance explained (h 2 ). We calculated h 2 using the fixed effects from the individual associations found in our current analysis and by Trynka et al. 3 . For this analysis, we used the methods previously described 9,10 and a disease prevalence in the population of 1%, 2% or 3% ( Supplementary Table 6 ).
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ONLINE METHODS

Subjects.
Informed consent was obtained for all samples used, and the study was approved by the ethics committees of each of the institutions involved. Individuals with celiac disease were identified by autoantibody testing and confirmed by an intestinal biopsy; they have been reported previously 3 .
Genotyping. We analyzed a total sample of 23,936 individuals, including 12,016 cases and 11,920 controls of European ancestry (Supplementary Table 1) . All samples were genotyped using the Illumina Immunochip platform, following standard quality control procedures, as described previously 3 .
Imputation of the HLA region. Using the Immunochip genotype data, we imputed 2-and 4-digit classical alleles for HLA-A, HLA-C, HLA-B, HLA-DRB1, HLA-DQA1, HLA-DQB1, HLA-DPA1 and HLA-DPB1 and their corresponding amino acid polymorphisms, on the basis of a reference panel of 5,225 individuals of European descent collected by the Type 1 Diabetes Genetics Consortium and using SNP2HLA 14, 16 . This reference panel has been used previously and showed high imputation quality for the HLA region in other studies 14, 17, 18 , as well as in our data (Supplementary Fig. 5 ).
Association analysis. We determined the top independent associations using a stepwise logistic regression model assuming additive effects of the allele dosages on the log(odds) scale. We included sex and a categorical variable representing each of the cohorts used in the analysis (n = 6) to account for effects specific to population or cohort. For the analysis, we included two-and four-digit biallelic HLA classical alleles, biallelic and multiallelic polymorphic amino acid positions, and biallelic SNPs across the entire MHC region. For HLA variants with m alleles (m = 2 for biallelic variants and m > 2 for multiallelic variants), we included m -1 alleles in the model, excluding the most frequent allele as a reference. This resulted in the following logistic regression model: where γ is the log(odds) for case-control status, β 0 is the logistic regression intercept, j indicates the specific allele being tested and x i,j corresponds to the dosage imputed or genotyped for allele j in individual i. The β i,j parameter represents the additive effect per allele. The sex covariate is represented in the model as l, and k in the last block in the model corresponds to the categorical covariate representing the different cohorts included in the analysis.
Throughout the text, we refer to such a model as alternative, reflecting the fact that only one variant was included in the model with the other covariates. We calculated an omnibus P value for each variant, independent of the number of alleles in the alternative model. For this calculation, we used a log-likelihood ratio test (equation (2)) comparing the likelihood L 0 of the null model (equation (3)) against the likelihood L 1 of the alternative-fitted model 18, 19 . The log-likelihood ratio test is represented by: 
